首页 › 基金 › Zweig-DiMenna Associates LLC › CDNA
Zweig-DiMenna Associates LLC 对 CDNA 的持仓历史
CAREDX INC · 医疗保健
Zweig-DiMenna Associates LLC 在 Q3 2026 的 13F 申报中披露持有 CDNA(CAREDX INC)389,812 股,市值约 US$25.3M,约占其申报组合的 2.01%,在其申报持仓中市值排名第 16 位。 Zweig-DiMenna Associates LLC 最近 6 个申报季度中有 6 个季度披露了 CDNA 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Zweig-DiMenna Associates LLC 对 CDNA 的持仓演变
Zweig-DiMenna Associates LLC 于 Q2 2025 首次披露 CDNA 持仓:226,600 股(约 US$4.4M)。 该持仓在 Q3 2026 达到峰值 389,812 股,市值约 US$25.3M。 在 6 次申报中,Zweig-DiMenna Associates LLC 2 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 389,812 股、市值约 US$25.3M。 持仓曾出现大幅变动:Q3 2025 增持约 154% (随后一个季度股价上涨 30%)、Q1 2026 减持约 43% (随后一个季度股价上涨 64%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 226.60K | $4.43M | 新进 |
| Q3 2025 | 575.00K | $8.36M | 增持 |
| Q4 2025 | 679.00K | $12.79M | 增持 |
| Q1 2026 | 390.25K | $6.77M | 减持 |
| Q2 2026 | 388.81K | $11.08M | 持有 |
| Q3 2026 | 389.81K | $25.34M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CDNA 与 13F 数据
CDNA(CAREDX INC)属于医疗保健行业。我们追踪的基金中还有 45 只申报持有 CDNA,申报仓位最大的包括:方舟投资 (US$104.6M), GAGNON SECURITIES LLC (US$69.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CDNA 的基金
- 方舟投资 1.61M 股 · $104.59M · Q3 2026
- GAGNON SECURITIES LLC 1.07M 股 · $69.84M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.00M 股 · $56.93M · Q2 2026
- Amova Asset Management Americas, Inc. 625.42K 股 · $40.63M · Q3 2026
- Ophir Asset Management Pty Ltd 1.26M 股 · $36.05M · Q2 2026
- BRAIDWELL LP 1.22M 股 · $34.79M · Q2 2026
- Blue Water Life Science Advisors, LP 1.19M 股 · $33.91M · Q2 2026
- Divisadero Street Capital Management, LP 700.94K 股 · $19.98M · Q2 2026
- Portolan Capital Management, LLC 684.80K 股 · $19.52M · Q2 2026
- Gagnon Advisors, LLC 286.89K 股 · $18.65M · Q3 2026
- Palo Alto Investors LP 531.87K 股 · $15.16M · Q2 2026
更多关于 Zweig-DiMenna Associates LLC
常见问题
How long has Zweig-DiMenna Associates LLC held CDNA?
Zweig-DiMenna Associates LLC has disclosed CDNA holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Zweig-DiMenna Associates LLC's current position in CDNA?
As of Q3 2026, Zweig-DiMenna Associates LLC holds 389.81K shares of CDNA (CAREDX INC), valued at $25.34M, representing 2.01% of its reported portfolio and ranking #16.
Has Zweig-DiMenna Associates LLC been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Zweig-DiMenna Associates LLC held unchanged its position in CDNA. The position peaked in Q3 2026 at 389.81K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include 方舟投资, GAGNON SECURITIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.